Screening scheme based on measurement of fluorescence lifetime in the nanosecond domain

Journal of Biomolecular Screening

Volumn 10, Issue 7, 2005, Pages 687-694

  Hoefelschweiger, Bianca K ^a   Pfeifer, Lutz ^b   Wolfbeis, Otto S ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b IOM Innovative Optische Messtechnik GmbH   (Germany)

Author keywords

Affinity assay; Affinity binding; Decay time; Fluorescent label; Laser induced fluorescence; Lifetime

Indexed keywords

BIOTIN; BOVINE SERUM ALBUMIN; CYANINE DYE; DEFERIPRONE; FLUORESCENT DYE; PY 1; PY 4; PY 6; STREPTAVIDIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BIOTINYLATION; DYE LASER; FLUORESCENCE; FLUORESCENCE LIFETIME AFFINITY ASSAY; HIGH THROUGHPUT SCREENING; PARAMETER; PRIORITY JOURNAL; STANDARD; TIME;

AFFINITY LABELS; BIOTIN; DRUG DELIVERY SYSTEMS; FLUORESCENT DYES; STREPTAVIDIN; TIME FACTORS;

BOVINAE;

EID: 26944494870     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057105277493     Document Type: Article

References (31)

1. Liu B, Li S, Hu J: Technological advances in high-throughput screening. Am J PharmacoGenomics 2004;4:263-276.
2. Wilson WD: Analyzing biomolecular interactions. Science 2002;295:2103-2105.
3. Doman TN, McGovern SL, Witherbee BJ, Kasten TP, Stallings WC, Connolly DT, et al: Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B. J Med Chem 2002;45:2213-2221.
4. Sills MA, Weiss D, Pham Q, Schweitzer R, Wu X, Wu JJ: Comparison of assay technologies for a tyrosine kinase assay generates different results in high throughput screening. J Biomol Screen 2002;7:191-214.
5. Steff AM, Fortin M, Arguin C, Hugo P: Detection of a decrease in green fluorescent protein fluorescence for the monitoring of cell death: an assay amenable to high-throughput screening technologies. Cytometry 2001;45:237-243.
6. Owicki JC: Fluorescence polarization and anisotropy in high throughput screening: perspectives and primer. J Biomol Screen 2000;5:297-306.
7. Medina MA, Schwille P: Fluorescence correlation spectroscopy for the detection and study of single molecules in biology. BioEssays 2002;24:758-764.
8. Roda A, Guardigli M, Pasini P, Mirasoli M: Bioluminescence and cherniluminescence in drug screening. Anal Bioanal Chem 2003;377:826-833.
9. Haupt K: Imprinted polymers: tailor-made mimics of antibodies and receptors. Chem Comm 2003;Jan 21(2):171-178.
10. Senholdt M, Siemann M, Mosbach K, Andersson LI: Determination of cyclosporin A and metabolites total concentration using a molecularly imprinted polymer based radioligand binding assay. Anal Lett 1997;30:1809-1821.
11. Wijayawardhana CA, Halsall HB, Heineman WR: Electrochemical immunoassay. In Bard AJ, Stratmann M (eds): Encyclopedia of Electrochemistry: Vol. 9. Bioelectrochemistry. Weinheim: Wiley-VCH, 2002:145, 147-174.
12. Stefan RI, van Staden JF, Aboul Enein HY: Design and use of electrochemical sensors in enantioselective high throughput screening of drugs: a minireview. Combinat Chem High Throughput Screen 2000;3:445-454.
13. Kerns EH: High throughput physicochemical profiling for drug discovery. J Pharm Sci 2001;90:1838-1858.
14. Huber C, Klimant I, Krause Ch, Wolfbeis OS: Dual lifetime referencing as applied to a chloride optical sensor. Anal Chem 2001;73:2097-2103.
15. Valeur B: Molecular Fluorescence, Principles and Applications. Weinheim: Wiley-VCH, 2002.
16. Liebsch G, Klimant I, Frank B, Holst G, Wolfbeis OS: Luminescence lifetime imaging of oxygen, pH, and carbon dioxide distribution using optical sensors. Appl Spectrosc 2000;54:548-559.
17. Hemmilä I, Webb S: Time-resolved fluorometry: an overview of the labels and core technologies for drug screening applications. Drug Discovery Today 1997;2:373-381.
18. Mathis G: Rare earth cryptates and homogeneous fluoroimmunoassays with human sera. Clin Chem 1993;39:1953-1959.
19. Christopoulos TK, Diamandis EP: Enzymatically amplified time-resolved fluorescence immunoassay with terbium chelates. Anal Chem 1992;64:342.
20. Duerkop A, Lehmann F, Wolfbeis OS: Polarization immunoassays using reactive ruthenium metal-ligand complexes as luminescent labels. Anal Bioanal Chem 2002;372:688-694.
21. Augustin CM, Oswald B, Wolfbeis OS: Time-resolved luminescence energy transfer immunobinding study using a ruthenium-ligand complex as a donor label. Anal Biochem 2002;305:166-172.
22. Jäger S, Brand L, Eggeling C: New fluorescence techniques for high-throughput drug discovery. Curr Pharm Biotechnol 2003;4:463-476.
23. Eggeling Ch, Brand L, Ullmann D, Jäger S : Highly sensitive fluorescence detection technology currently available for HTS. Drug Discovery Today 2003;8:632-641.
24. French TE, Bailey B, Stumbo DP, Modlin DN: Time-resolved fluorometer for high-throughput screening. Proc Soc Photoinstrum Eng (SPIE) 1999;3603:272-280.
25. Turconi S, Bingham RP, Haupts U, Pope AJ: Developments in fluorescence lifetime-based analysis for ultra-HTS. Drug Discovery Today 2001;6:S27-S39.
26. Gruber M, Oswald B, Wetzl B, Enderlein J, Wolfbeis OS: Long wavelength absorbing fluorophores and their application to oligonucleotide labeling and fluorescence resonance energy transfer (FRET) hybridization studies. J Fluorescence 2005;15:2007-2014.
27. Wetzl BK, Yarmoluk SM, Craig DB, Wolfbeis OS: Chameleon labels for staining and quantifying of proteins. Angew Chem Int Ed 2004;43:5400-5402.
28. Kostenko OM, Dmitrieva SY, Tolrnachev OL Yarmoluk SM: New approach for fluorescent peptide labeling with pyrylium cyanine dyes. J Fluoresc 2002;12:173-175.
29. Huang S, Stump MD, Weiss R, Caldwell KD: Binding of biotinylated DNA to streptavidin-coated polystyrene latex: effects of chain length and particle size. Anal Biochem 1996;237:115-122.
30. Diamandis EP, Christopoulos TK: Europium chelate labels in time-resolved immunoassays and DNA hybridization assays. Anal Chem 1990;62:1149A-1157A.
31. Zhang JH, Chung TD, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high-throughput screening assays. J Biomol Screen 1999;4:67-73.